Respiratory Drug Delivery Market Growth, Trends, Opportunities and Forecast to 2030 - 3M, GlaxoSmithKline, AstraZeneca, Novartis

Respiratory drug delivery offers treatment for diseases of the respiratory tract through noninvasive means to deliver either topically active medications or systemic drugs to target organs. The nose and lung are the target organs for the deposition of the aerosol drug.In asthma, drug delivery to the upper airways is needed while for alveolar lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis, it is important to have drug deposition deep within the lungs rather than just the upper airways.

Market Industry Reports (MIR) has published a new report titled "Respiratory Drug Delivery Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030." According to the report, the Global Respiratory Drug Delivery Market accounted for over US$ 39 billion in 2019. It is anticipated to grow at a CAGR of approximately 6.8% from 2020 to 2030.

Major Key Players of the Respiratory Drug Delivery Market are:3M, GlaxoSmithKline plc., AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH., Philips Respironics, Merck & Co., Inc., OMRON Healthcare, Cipla Inc., and others.

Read More @ http://www.sbwire.com/press-releases/respiratory-drug-delivery-market-growth-trends-opportunities-and-forecast-to-2030-3m-glaxosmithkline-astrazeneca-novartis-1287293.htm